株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

人工多能性幹細胞 (iPS細胞) :世界市場

Induced Pluripotent Stem Cells: Global Markets

発行 BCC Research 商品コード 306082
出版日 ページ情報 英文 139 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.21円で換算しております。
Back to Top
人工多能性幹細胞 (iPS細胞) :世界市場 Induced Pluripotent Stem Cells: Global Markets
出版日: 2017年06月29日 ページ情報: 英文 139 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界の人工多能性幹細胞 (iPS細胞) 市場は、2016年に21億米ドルに達しました。市場は、2016年〜2021年のCAGR (複合年間成長率) で、11.6%の成長が予測されています。

当レポートでは、世界の人工多能性幹細胞 (iPS細胞) について調査分析し、市場概要、市場動向・予測、製品、技術、市場需要に影響を与える要因、主要企業プロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 概要

  • イントロダクション
  • 経緯と現状
  • iPS細胞研究の進化
  • iPS細胞の利点と欠点
  • 技術概要

第4章 iPS細胞の応用

  • 学術研究
  • 薬物毒性スクリーニング
  • 疾患モデリング
  • 再生医療
  • 細胞療法

第5章 iPS細胞市場区分と予測

  • iPS細胞市場概要
  • 応用別の市場概要
  • 米国のiPS細胞製品市場
  • iPS細胞由来の組織細胞市場
  • iPS細胞と派生細胞市場
  • iPS細胞製品の主要サプライヤーとメーカー
  • iPS細胞由来の細胞市場:応用別
  • 研究市場 vs. 臨床市場
  • iPS細胞由来の細胞向け応用別市場
  • iPS細胞とその由来の細胞市場:種別
  • iPS細胞培養市場

第6章 iPS細胞研究応用市場

  • 製品タイプ
  • 主要企業
  • 市場シェアと予測

第7章 創薬・開発市場

  • 製品タイプ
  • 主要企業
  • 市場シェアと予測

第8章 iPS細胞受託サービス市場

  • サービスタイプ
  • 主要企業
  • 市場シェアと予測

第9章 iPS細胞臨床応用市場

  • 製品タイプ
  • 規制
  • 市場予測

第10章 研究市場の動向分析

  • 助成金分析
  • 特許分析
  • 科学出版物分析
  • 促進要因

第11章 臨床応用市場の動向分析

  • 治験
  • 促進要因
  • 阻害要因

第12章 企業プロファイル

第13章 結論

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BIO135B

The global market for induced pluripotent stem cells (iPSCs) reached $2.1 billion in 2016. The market should reach $3.6 billion in 2021, increasing at a compound annual growth rate (CAGR) of 11.6% from 2016 through 2021.

Report Includes

  • An overview of the global market for induced pluripotent stem cells.
  • Analyses of global market trends with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Information on induced pluripotent stem cell research products, defined as all research tools including but not limited to: induced pluripotent stem cells and various differentiated cells derived from induced pluripotent stem cells; various related assays and kits, culture media and medium components, such as serum, growth factors and inhibitors, antibodies, enzymes, and many others that can be applied for the specific purpose of executing induced pluripotent stem cell research.
  • Discussion of important manufacturers, technologies, and factors influencing market demand, such as the driving forces and limiting factors of induced pluripotent stem cell market growth.
  • Profiles of major players in the industry.

Report Scope

This study is focused on the market side of iPSCs rather than its technical side. Different market segments for this emerging market are covered. For example, application-based market segments include academic research, drug development and toxicity testing, and regenerative medicine; product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation and cell analysis; iPSC-derived cell-type-based market segments include cardiomyocytes, hepatocytes, neurons, endothelia cells and other cell types; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also analyzed by studying the funding, patent publications and research publications in the field.

Analyst Credentials

Mike Fan is a life science marketing and product management professional with more than 20 years of experience cover multiple biotech R&D areas, as well as life science marketing in both academia and industry. Mike has a broad range of technical skills in chemical and biological area and holds a PhD in Chemical Engineering and a Master of Business Administration focusing on Marketing.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of Report
  • Methodology
  • Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Key Drivers for Market Growth

Chapter 3: Overview

  • Introduction
  • History and Current State
  • Evolution of Induced Pluripotent Stem Cell Research
  • Induced Pluripotent Stem Cell Advantages and Disadvantages
    • Advantages
    • Disadvantages
  • Technology Overview
    • Induced Pluripotent Stem Cell Generation
    • Induced Pluripotent Stem Cell Differentiation

Chapter 4: Induced Pluripotent Stem Cell Applications

  • Academic Research
  • Pharmaco-Toxicological Screening
  • Drug Discovery and Development
  • Disease Modeling
  • Tissue Engineering
  • Cell Therapy

Chapter 5: Induced Pluripotent Stem Cell Market Segmentation and Forecast

  • Induced Pluripotent Stem Cell Market Overview
  • Application-Based Market Overview
  • U.S. Induced Pluripotent Stem Cell Product Market
  • Induced Pluripotent Stem Cell-Derived Tissue Cell Market
  • Induced Pluripotent Stem Cell and Derivative Cell Market
  • Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
  • Induced Pluripotent Stem Cell-Derived Cell Markets by Application
  • Induced Pluripotent Stem Cell Market by Product Function
    • Global Market
    • Regional Markets
  • Research Market vs. Clinical Market
  • Application-Based Markets for Induced Pluripotent Stem Cell-Derived Cells
    • Market for Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells
    • Market for Human Hepatocytes Derived from Induced Pluripotent Stem Cells
    • Market for Human Endothelia Cells Derived from Induced Pluripotent Stem Cells
    • Regional Markets
    • Market for Human Neural Cells Derived from Induced Pluripotent Stem Cells
    • Regional Markets
  • Induced Pluripotent Stem Cells and Their Derived Cells Market by Species
    • Global Market
    • Regional Markets
  • Induced Pluripotent Stem Cell Culture Markets

Chapter 6: Induced Pluripotent Stem Cell Research Application Market

  • Induced Pluripotent Stem Cell Research Product Types
  • Major Players
    • Major Commercial Entities
    • Major Non-Commercial Organizations
  • Market Shares and Projections

Chapter 7: Drug Discovery and Development Market

  • Product Types
  • Major Players
  • Market Shares and Projections

Chapter 8: Induced Pluripotent Stem Cell Contract Service Market

  • Induced Pluripotent Stem Cell Contract Service Types
  • Major Players
  • Market Shares and Projections

Chapter 9: Induced Pluripotent Stem Cell Clinical Application Market

  • Product Types
  • Regulations
  • Market Projection

Chapter 10: Research Market Trend Analysis

  • Grant Analysis
  • Patent Analysis
  • Scientific Publication Analysis
  • Driving Forces.

Chapter 11: Clinical Application Market Trend Analysis

  • Clinical Trials
  • Driving Forces.
  • Limiting Factors
    • Technologies
    • Regulations
    • Market Acceptance
    • Clinical Efficiency

Chapter 12: Company Profiles

Chapter 13: Conclusions

  • About BCC Research
  • About BCC Research
  • BCC Membership
  • BCC Custom Research

List of Tables

  • Summary Table: Global Induced Pluripotent Stem Cell Market, by Region, Through 2021 ($ Millions)
  • Table 1 U.S. Induced Pluripotent Stem Cell Product Market, by State, Through 2021 ($ Millions)
  • Table 2 Global Market for Methods for Generating Induced Pluripotent Stem Cells (Integrated and Non-Integrated), Through 2021 ($ Millions)
  • Table 3 Global Market for Methods for Generating Induced Pluripotent Stem Cells, Through 2021 ($ Millions)
  • Table 4 Global Market for Induced Pluripotent Stem Cell Products, by Application, Through 2021 ($ Millions)
  • Table 5 U.S. Induced Pluripotent Stem Cell Product Market, by Application, Through 2021 ($ Millions)
  • Table 6 Global Market for Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, Through 2021 ($ Millions)
  • Table 7 Global Market for Induced Pluripotent Stem Cell Derived Cells, by Species, Through 2021 ($ Millions)
  • Table 8 Major Commercial Induced Pluripotent Stem Cell Product Suppliers, March 31, 2017
  • Table 9 Major Commercial Induced Pluripotent Stem Cell Product Manufacturers, March 31, 2017
  • Table 10 Global Market for Induced Pluripotent Stem Cell-Derived Cells, by Application, Through 2021 ($ Millions)
  • Table 11 Global Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2021 ($ Millions)
  • Table 12 U.S. Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2021 ($ Millions)
  • Table 13 Global Markets for Induced Pluripotent Stem Cells, by Research and Clinical Use, Through 2021 ($ Millions)
  • Table 14 Global Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2021 ($ Millions)
  • Table 15 U.S. Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2021 ($ Millions)
  • Table 16 European Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2021 ($ Millions)
  • Table 17 Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2021 ($ Millions)
  • Table 18 Global Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2021 ($ Millions)
  • Table 19 U.S. Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2021 ($ Millions)
  • Table 20 European Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2021 ($ Millions)
  • Table 21 Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2021 ($ Millions)
  • Table 22 Global Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through 2021 ($ Millions)
  • Table 23 U.S. Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through 2021 ($ Millions)
  • Table 24 European Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through2021 ($ Millions)
  • Table 25 Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through 2021 ($ Millions)
  • Table 26 Global Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2021 ($ Millions)
  • Table 27 U.S. Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2021 ($ Millions)
  • Table 28 European Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2021 ($ Millions)
  • Table 29 Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2021 ($ Millions)
  • Table 30 Global Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2021 ($ Millions)
  • Table 31 U.S. Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2021 ($ Millions)
  • Table 32 European Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2021 ($ Millions)
  • Table 33 Asia-Pacific Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2021 ($ Millions)
  • Table 34 Global Market for Cell Culture Products for Induced Pluripotent Stem Cells and Derived Cells, by Region, Through 2021 ($ Millions)
  • Table 35 Global Market for Induced Pluripotent Stem Cell-Related Products, by Function, Through 2021 ($ Millions)
  • Table 36 U.S. Market for Induced Pluripotent Stem Cell-Related Products, by Function, Through 2021 ($ Millions)
  • Table 37 Global Market for Induced Pluripotent Stem Cell-Derived Cell Products for Research, by Cell Type, Through 2021 ($ Millions)
  • Table 38 Global Market for Induced Pluripotent Stem Cell Research, by Region, Through 2021 ($ Millions)
  • Table 39 Major University and Institute Induced Pluripotent Stem Cell Core Facilities, by Location
  • Table 40 Global Market for Induced Pluripotent Stem Cell-Derived Cell Products for Drug Development and Toxicity Testing, by Cell Type, Through2021 ($ Millions)
  • Table 41 Global Market for Induced Pluripotent Stem Cell Drug Development and Toxicity Testing, by Region, Through 2021 ($ Millions)
  • Table 42 Major Companies Providing Induced Pluripotent Stem Cell Contract Services, 2016
  • Table 43 Global Market for Induced Pluripotent Stem Cell Contract Services, by Region, Through 2021 ($ Millions)
  • Table 44 Global Market for Induced Pluripotent Stem Cell Products for Regenerative Medicine, by Cell Type, Through 2021 ($ Millions)
  • Table 45 Induced Pluripotent Stem Cell Clinical Global Markets (Including Patient-Specific Induced Pluripotent Stem Cell Banking), by Region, Through 2021 ($ Millions)
  • Table 46 Major Governmental Induced Pluripotent Stem Cell Research Funding, by Region, 2006-2016 ($ Millions/%)
  • Table 47 National Institutes of Health Induced Pluripotent Stem Cell Research Funding, FY 2006-2016 (Number of Grants/$ Millions)
  • Table 48 California Institute of Regenerative Medicine Induced Pluripotent Stem Cell Funding, Through January 2017 (Number/$Millions)
  • Table 49 Induced Pluripotent Stem Cell Patents Issued, by the U.S. Patent and Trademark Office, 2011 to December 2016
  • Table 50 U.S. Patent and Trademark Office-Issued Patents, by Region, 2011 to December 2016 (Number/%)
  • Table 51 Distribution of Induced Pluripotent Stem Cell Patents and Patent Applications with WIPO, by Filing Office or Country, 2011 to October 2016 (Number/%)
  • Table 52 Main Inventors of Global Induced Pluripotent Stem Cell Patents or Patent Applications, 2011 to October 2016 (Number/%)
  • Table 53 Main Applicants of Global Induced Pluripotent Stem Cell Patent Applications, 2011 to October 2016 (Number/%)
  • Table 54 World Intellectual Property Office Induced Pluripotent Stem Cell Patent Publications, by Year, 2007-2016 (Number)
  • Table 55 U.S. Patent and Trademark Office Induced Pluripotent Stem Cell Patent Applications, 2009-2016 (Number)
  • Table 56 Global Distribution of Induced Pluripotent Stem Cell Patents and Patent Applications with USPTO, by Country, Through 2016 (Number of Patents/%)
  • Table 57 U.S. Induced Pluripotent Stem Cell Patents and Patent Applications by State, Through 2016 (Number/%)
  • Table 58 World Intellectual Property Organization Induced Pluripotent Stem Cell Patent Publications, by Category, Through 2016 (Number/%)
  • Table 59 Induced Pluripotent Stem Cell Publications, 2006-2016 (Number)

List of Figures

  • Summary Figure: Global Induced Pluripotent Stem Cell Market, by Region, 2015-2021 ($ Millions)
  • Figure 1 Global Induced Pluripotent Stem Cell Product Market Shares, by Region, 2021 (%)
  • Figure 2 U.S. Induced Pluripotent Stem Cell Product Market Shares, by State, 2021 (%)
  • Figure 3 Global Market Shares for Generating Induced Pluripotent Stem Cells, by Methods, 2021 (%)
  • Figure 4 Global Market Shares for Generating Induced Pluripotent Stem Cells, by Methods, 2021 (%)
  • Figure 5 Global Market Shares for Induced Pluripotent Stem Cell Products, by Application, 2021 (%)
  • Figure 6 U.S. Market Shares for Induced Pluripotent Stem Cell Products, by Application, 2021 (%)
  • Figure 7 Global Market Shares for Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, 2021 (%)
  • Figure 8 Major Commercial Induced Pluripotent Stem Cell Suppliers, by Country, 2016
  • Figure 9 Major U.S. Commercial Induced Pluripotent Stem Cell Product Suppliers, by State, 2016
  • Figure 10 Major Commercial Induced Pluripotent Stem Cell Product Manufacturers, by Country, 2016
  • Figure 11 Major U.S. Commercial Induced Pluripotent Stem Cell Product Manufacturers, by State, 2016.
  • Figure 12 Global Market Shares for Induced Pluripotent Stem Cell-Derived Cells, by Application, 2021 (%)
  • Figure 13 Global Market Shares for Induced Pluripotent Stem Cells, by Product Function, 2021 (%)
  • Figure 14 U.S. Market Shares for Induced Pluripotent Stem Cells, by Product Function, 2021 (%)
  • Figure 15 Global Market Shares for Induced Pluripotent Stem Cells, by Research and Clinical Use, 2021 (%)
  • Figure 16 Global Market Shares for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2021 (%)
  • Figure 17 U.S. Market Shares for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2021 (%)
  • Figure 18 European Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2021 (%)
  • Figure 19 Asia-Pacific Market Shares for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2021 (%)
  • Figure 20 Global Market Shares for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2021 (%)
  • Figure 21 U.S. Market Shares for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2021 (%)
  • Figure 22 European Market Shares for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2021 (%)
  • Figure 23 Asia-Pacific Market Shares for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2021 (%)
  • Figure 24 Global Market Shares for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2021 (%)
  • Figure 25 U.S. Market Shares for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2021 (%)
  • Figure 26 European Market Shares for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2021 (%)
  • Figure 27 Asia-Pacific Market Shares for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2021 (%)
  • Figure 28 Global Market Shares for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2021 (%)
  • Figure 29 U.S. Market Shares for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2021 (%)
  • Figure 30 European Market Shares for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2021 (%)
  • Figure 31 Asia-Pacific Market Shares for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2021 (%)
  • Figure 32 Global Market Shares for Induced Pluripotent Stem Cells and Derivative Cells, by Species, 2021 (%)
  • Figure 33 Global Market Shares for Induced Pluripotent Stem Cell Culture Products, by Region, 2021 (%)
  • Figure 34 Global Market Shares for Induced Pluripotent Stem Cells, by Product Function, 2021 (%)
  • Figure 35 U.S. Market Shares for Induced Pluripotent Stem Cells, by Product Function, 2021 (%)
  • Figure 36 Global Market Shares for Induced Pluripotent Stem Cell-Derived Cell Research, by Cell Type, 2021 (%)
  • Figure 37 Global Market Shares for Induced Pluripotent Stem Cell Research, by Region, 2021 (%)
  • Figure 38 Global Market Shares for Induced Pluripotent Stem Cell-Derived Cells Drug Development and Toxicity Testing, by Cell Type, 2021 (%)
  • Figure 39 Global Market Shares for Induced Pluripotent Stem Cell Drug Development and Toxicity Testing, by Region, 2021 (%)
  • Figure 40 Global Market Shares for Induced Pluripotent Stem Cell Contract Services, by Region, 2021 (%)
  • Figure 41 Global Market Shares for Induced Pluripotent Stem Cell-Derived Regenerative Medicine, by Cell Type, 2021 (%)
  • Figure 42 Induced Pluripotent Stem Cell Clinical Global Market Shares, by Region, 2021 (%)
  • Figure 43 Major Governmental Induced Pluripotent Stem Cell Research Funding, by Region, 2006-2016 (%)
  • Figure 44 National Institutes of Health Induced Pluripotent Stem Cell Research Funding, 2006-2016 ($ Millions)
  • Figure 45 World Intellectual Property Office Induced Pluripotent Stem Cell Patent Applications, 2007-2016 (Number)
  • Figure 46 U.S. Patent and Trademark Office Induced Pluripotent Stem Cell Patent Applications, 2009-2016 (Number)
  • Figure 47 Induced Pluripotent Stem Cell Research Publications, 2006-2016 (Number)
Back to Top